Delivery Order SPE2DB22D3501-SPE2DB26FTH50
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,618.70 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. The contract employs firm fixed pricing and was competitively awarded without set-aside restrictions, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,806.98 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,492.15 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 ml pharmaceutical product, with an ultimate completion date of June 9, 2025. This competitively awarded, firm fixed-price delivery order was issued on June 6, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this order, which is being performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,598.16 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical supplies. This competitive award, issued on July 15, 2025, with an ultimate completion date of July 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products, with a ceiling value of $2,202.89. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 27, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.78 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,012.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,620.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 and running through December 31, 2025. The IDC serves as Amerisourcebergen's primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $5,845.32 contract is for the delivery of the pharmaceutical product "NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML" with a completion date of March 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) that DLA has with AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,793.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 ml pharmaceutical supplies, with an ultimate completion date of July 1, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. The products will be delivered to the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH50Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,981.40 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 ml pharmaceutical product, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the overarching vehicle for this delivery order. This prime contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates extensive capability in fulfilling medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/29/25 |